Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03424122 |
|---|---|
| Brief Title: | INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112) |
| First Submitted : | January 25, 2018 |
| First Submitted that Met QC Criteria : | January 31, 2018 |
| First Posted : | February 6, 2018 |
| Last Update Submitted that Met QC Criteria : | June 27, 2022 |
| Last Update Posted : | June 29, 2022 |